American Portfolios Advisors Fortress Biotech, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Fortress Biotech, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 450 shares of FBIO stock, worth $751. This represents 0.0% of its overall portfolio holdings.
Number of Shares
450Holding current value
$751% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FBIO
# of Institutions
6Shares Held
1.01MCall Options Held
0Put Options Held
0-
Cpwm, LLC Seattle, WA762KShares$1.27 Million0.06% of portfolio
-
National Asset Management, Inc. Boca Raton, FL145KShares$241,6490.01% of portfolio
-
Telemetry Investments, L.L.C. New York, NY72KShares$120,2400.07% of portfolio
-
Dowling & Yahnke LLC San Diego, CA20KShares$33,4000.01% of portfolio
-
Urban Wealth Management, LLC7.64KShares$12,7500.02% of portfolio
About Fortress Biotech, Inc.
- Ticker FBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,735,000
- Market Cap $180M
- Description
- Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...